Concepedia

Author

Harald Stein

Charité - Universitätsmedizin Berlin

Also Known As

H F STEIN, H STEIN, H Stein, H. Stein, HARALD STEIN, Harald Stein, Monika Szczepanowski, Stein, Harald

307

Publications

33.3K

Citations

74

H-Index

155

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinFreie Universität BerlinFranklin UniversityUniversity of LübeckUniversity Hospital Schleswig-Holstein
HS

About

Harald Stein is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

40

70

11.3K

2

Health Sciences

9

9

1.1K

3

Allergy

4

4

138

4

Public Health

2

2

55

5

Natural Sciences

1

1

43

Harald Stein

×

176

Publications

22.3K

Citations

71

H-Index

YearCitations

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Johannes Gerdes, Hilmar Lemke, H. Baisch,

The Journal of Immunology

1984

4.2K

Oncogene-induced senescence as an initial barrier in lymphoma development

Melanie Braig, Soyoung Lee, Christoph Loddenkemper,

Nature

2005

1.2K

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Michael Hummel, Stefan Bentink, Hilmar Berger,

New England Journal of Medicine

2006

1K

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Andreas Engert, Heinz Haverkamp, Carsten Kobe,

The Lancet

2012

621

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore, Vindi Jurinović, Robert Kridel,

The Lancet Oncology

2015

608

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Heike Horn, Marita Ziepert, Claudia Becher,

Blood

2013

540

Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma

Franziska Jundt, Ioannis Anagnostopoulos, Reinhold Förster,

Blood

2002

398

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe,

The Lancet

2017

372

Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

Volker Diehl, M. Sextro, Jeremy Franklin,

Journal of Clinical Oncology

1999

364

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

Björn Lamprecht, Korden Walter, Stephan Kreher,

Nature Medicine

2010

360

Page 1